A clinical study of Mycobacterium vaccae (M.vaccae) for injection.

Trial Profile

A clinical study of Mycobacterium vaccae (M.vaccae) for injection.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Mycobacterium vaccae vaccine (Primary)
  • Indications Mycobacterial infections
  • Focus Pharmacodynamics; Registrational
  • Sponsors AnHui Longcom Biologic Pharmacy
  • Most Recent Events

    • 21 May 2012 Actual end date changed from 30 Jun 2008 to 21 Mar 2009 as reported by Chinese Clinical Trial Register.
    • 27 Jul 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top